|
1
|
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.
|
Nature
|
2003
|
9.79
|
|
2
|
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
|
J Biol Chem
|
2006
|
5.57
|
|
3
|
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.
|
J Biol Chem
|
2002
|
4.16
|
|
4
|
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy.
|
Cancer
|
2007
|
2.43
|
|
5
|
Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle.
|
Cell Metab
|
2011
|
2.42
|
|
6
|
Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer.
|
AJR Am J Roentgenol
|
2008
|
1.66
|
|
7
|
Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value.
|
Magn Reson Med Sci
|
2004
|
1.39
|
|
8
|
Distributions of beta+ decayed nuclei generated in the CH2 and H2O targets by the target nuclear fragment reaction using therapeutic MONO and SOBP proton beam.
|
Med Phys
|
2005
|
1.29
|
|
9
|
Spectrum of FDG PET/CT findings of uterine tumors.
|
AJR Am J Roentgenol
|
2010
|
1.23
|
|
10
|
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
|
Breast Cancer
|
2007
|
1.23
|
|
11
|
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
|
Ann Nucl Med
|
2009
|
1.21
|
|
12
|
Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
|
Jpn J Clin Oncol
|
2007
|
1.19
|
|
13
|
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.
|
Eur J Nucl Med Mol Imaging
|
2008
|
1.12
|
|
14
|
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
|
Gastric Cancer
|
2011
|
1.09
|
|
15
|
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
|
Eur J Nucl Med Mol Imaging
|
2008
|
1.09
|
|
16
|
FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study.
|
Ann Nucl Med
|
2011
|
1.09
|
|
17
|
Structure of orbitofrontal cortex and its longitudinal course in cancer-related post-traumatic stress disorder.
|
Neurosci Res
|
2007
|
1.03
|
|
18
|
Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.
|
Eur J Nucl Med Mol Imaging
|
2008
|
1.02
|
|
19
|
Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique.
|
Jpn J Clin Oncol
|
2004
|
1.01
|
|
20
|
Identification of bioactive molecules by adipogenesis profiling of organic compounds.
|
J Biol Chem
|
2002
|
1.01
|
|
21
|
No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors.
|
Breast Cancer Res Treat
|
2005
|
0.99
|
|
22
|
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.98
|
|
23
|
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
|
Lung Cancer
|
2005
|
0.97
|
|
24
|
Prefrontal cortex and amygdala volume in first minor or major depressive episode after cancer diagnosis.
|
Biol Psychiatry
|
2005
|
0.96
|
|
25
|
Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
|
Atherosclerosis
|
2009
|
0.95
|
|
26
|
Comparison of DWI and PET/CT in evaluation of lymph node metastasis in uterine cancer.
|
World J Radiol
|
2012
|
0.93
|
|
27
|
Escherichia coli pneumonia in combination with fungal sinusitis and meningitis in a tsunami survivor after the Great East Japan Earthquake.
|
Tohoku J Exp Med
|
2012
|
0.93
|
|
28
|
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
|
Eur Radiol
|
2009
|
0.93
|
|
29
|
Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
|
Med Sci Monit
|
2004
|
0.91
|
|
30
|
Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study.
|
Jpn J Clin Oncol
|
2009
|
0.90
|
|
31
|
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.
|
Eur Radiol
|
2008
|
0.90
|
|
32
|
Regional cerebral glucose metabolism in patients with secondary depressive episodes after fatal pancreatic cancer diagnosis.
|
J Affect Disord
|
2006
|
0.90
|
|
33
|
Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
|
Oncol Rep
|
2003
|
0.88
|
|
34
|
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition.
|
J Hepatobiliary Pancreat Sci
|
2015
|
0.88
|
|
35
|
Unsaturated FAs prevent palmitate-induced LOX-1 induction via inhibition of ER stress in macrophages.
|
J Lipid Res
|
2010
|
0.88
|
|
36
|
Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.
|
Proc Natl Acad Sci U S A
|
2011
|
0.88
|
|
37
|
Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
|
Lung Cancer
|
2007
|
0.88
|
|
38
|
Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes.
|
J Lipid Res
|
2011
|
0.87
|
|
39
|
Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumors.
|
Jpn J Clin Oncol
|
2006
|
0.86
|
|
40
|
Cancer-related intrusive thoughts as an indicator of poor psychological adjustment at 3 or more years after breast surgery: a preliminary study.
|
Breast Cancer Res Treat
|
2002
|
0.86
|
|
41
|
Sarcoid-like reaction mimics progression of disease after induction chemotherapy for lung cancer.
|
Ann Thorac Surg
|
2010
|
0.86
|
|
42
|
Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate.
|
Cancer Chemother Pharmacol
|
2009
|
0.85
|
|
43
|
Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
|
Biochem Pharmacol
|
2007
|
0.85
|
|
44
|
A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
|
Am J Physiol Endocrinol Metab
|
2008
|
0.85
|
|
45
|
Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
|
Ann Nucl Med
|
2008
|
0.84
|
|
46
|
Relationship between distressing cancer-related recollections and hippocampal volume in cancer survivors.
|
Am J Psychiatry
|
2002
|
0.84
|
|
47
|
Involvement of protein kinase C in glutamate release from cultured microglia.
|
Brain Res
|
2003
|
0.84
|
|
48
|
Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier.
|
Microvasc Res
|
2011
|
0.84
|
|
49
|
Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
|
Ann Nucl Med
|
2011
|
0.83
|
|
50
|
Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
|
Mol Cancer Ther
|
2004
|
0.83
|
|
51
|
Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes.
|
J Lipid Res
|
2010
|
0.83
|
|
52
|
Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy.
|
Cancer Med
|
2014
|
0.83
|
|
53
|
Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
|
Biochem Pharmacol
|
2009
|
0.83
|
|
54
|
Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor.
|
Biochim Biophys Acta
|
2010
|
0.83
|
|
55
|
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
|
Mol Imaging Biol
|
2009
|
0.83
|
|
56
|
Suppression of FoxO1/cell death-inducing DNA fragmentation factor α-like effector A (Cidea) axis protects mouse β-cells against palmitic acid-induced apoptosis.
|
Mol Cell Endocrinol
|
2011
|
0.82
|
|
57
|
A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes.
|
J Lipid Res
|
2013
|
0.81
|
|
58
|
Pharmacological characterization of a human-specific peroxisome proliferater-activated receptor alpha (PPARalpha) agonist in dogs.
|
Biochem Pharmacol
|
2004
|
0.81
|
|
59
|
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
|
Brain Res
|
2011
|
0.81
|
|
60
|
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
|
Ann Nucl Med
|
2008
|
0.81
|
|
61
|
Clinical significance of performing 18F-FDG PET on patients with gastrointestinal stromal tumors: a summary of a Japanese multicenter study.
|
Ann Nucl Med
|
2009
|
0.81
|
|
62
|
Thymic MALT lymphoma: MR imaging findings and their correlation with histopathological findings on four cases.
|
Clin Imaging
|
2004
|
0.80
|
|
63
|
Efficacy of MR mammography (MRM) in providing preoperative locoregional information on breast cancer: correlation between MRM and histological findings.
|
Magn Reson Med Sci
|
2002
|
0.80
|
|
64
|
Overexpression of retinoic acid receptor alpha in hepatocellular carcinoma.
|
Clin Cancer Res
|
2003
|
0.80
|
|
65
|
Hippocampal volume and first major depressive episode after cancer diagnosis in breast cancer survivors.
|
Am J Psychiatry
|
2004
|
0.80
|
|
66
|
Chemical genetic identification of the IGF-linked pathway that is mediated by STAT6 and MFP2.
|
Chem Biol
|
2006
|
0.79
|
|
67
|
A case of skeletal tuberculosis and psoas abscess: disease activity evaluated using (18) F-fluorodeoxyglucose positron emission tomography-computed tomography.
|
BMC Med Imaging
|
2013
|
0.79
|
|
68
|
Hippocampal and amygdalar volumes in breast cancer survivors with posttraumatic stress disorder.
|
J Neuropsychiatry Clin Neurosci
|
2008
|
0.79
|
|
69
|
Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model.
|
PLoS One
|
2012
|
0.79
|
|
70
|
High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
|
Acta Radiol
|
2013
|
0.79
|
|
71
|
Present and future of FDG-PET/CT in ovarian cancer.
|
Ann Nucl Med
|
2010
|
0.78
|
|
72
|
Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma.
|
Jpn J Cancer Res
|
2002
|
0.78
|
|
73
|
Positron emission tomography for preoperative staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis.
|
Hepatogastroenterology
|
2008
|
0.78
|
|
74
|
Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study.
|
Ann Nucl Med
|
2011
|
0.77
|
|
75
|
PET/CT supports breast cancer diagnosis and treatment.
|
Breast Cancer
|
2008
|
0.77
|
|
76
|
Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators.
|
J Med Chem
|
2003
|
0.77
|
|
77
|
SAR and biological evaluation of analogues of a small molecule histone deacetylase inhibitor N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide (MGCD0103).
|
Bioorg Med Chem Lett
|
2008
|
0.77
|
|
78
|
Extracellular superoxide dismutase in cultured astrocytes: decrease in cell-surface activity and increase in medium activity by lipopolysaccharide-stimulation.
|
Neurochem Res
|
2012
|
0.77
|
|
79
|
Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
|
Eur J Radiol
|
2008
|
0.77
|
|
80
|
Metabolic Tumor Volume and Total Lesion Glycolysis in PET/CT Correlate With the Pathological Findings of Colorectal Cancer and Allow Its Accurate Staging.
|
Clin Nucl Med
|
2016
|
0.76
|
|
81
|
Cavum septi pellucidi and intrusive recollections in cancer survivors.
|
Neurosci Res
|
2006
|
0.76
|
|
82
|
Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.
|
Tumour Biol
|
2009
|
0.76
|
|
83
|
Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone.
|
J Med Chem
|
2010
|
0.76
|
|
84
|
Uni-directional differentiation of mouse embryonic stem cells into neurons by the neural stem sphere method.
|
Neurosci Res
|
2010
|
0.76
|
|
85
|
Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARalpha-selective activators.
|
Bioorg Med Chem Lett
|
2002
|
0.76
|
|
86
|
[Follow-up after curative surgery for colorectal cancer: impact of positron emission tomography - computed tomography (PET/CT)].
|
Rev Gastroenterol Peru
|
2011
|
0.76
|
|
87
|
Enantio-dependent binding and transactivation of optically active phenylpropanoic acid derivatives at human peroxisome proliferator-activated receptor alpha.
|
Bioorg Med Chem Lett
|
2002
|
0.76
|
|
88
|
Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
|
Am J Physiol Endocrinol Metab
|
2009
|
0.76
|
|
89
|
Flagellin/TLR5 signaling potentiates airway serous secretion from swine tracheal submucosal glands.
|
Am J Physiol Lung Cell Mol Physiol
|
2013
|
0.75
|
|
90
|
Middle bile duct cancer with portal vein tumor thrombus.
|
World J Surg Oncol
|
2008
|
0.75
|
|
91
|
Quinolone derivatives containing strained spirocycle as orally active glycogen synthase kinase 3β (GSK-3β) inhibitors for type 2 diabetics.
|
Bioorg Med Chem
|
2011
|
0.75
|
|
92
|
Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.
|
Surg Today
|
2012
|
0.75
|
|
93
|
Chronic leptin treatment stimulates lipid oxidation in immortalized and primary mouse skeletal muscle cells.
|
Biochim Biophys Acta
|
2008
|
0.75
|
|
94
|
Clinical practice guideline for dedicated breast PET.
|
Ann Nucl Med
|
2014
|
0.75
|
|
95
|
Optimization of Gd-DTPA-enhanced balanced turbo field echo sequence in abdominal imaging: clinical application.
|
Magn Reson Med Sci
|
2004
|
0.75
|
|
96
|
Positron emission tomography and breast lesions: low FDG activity in early phase imaging is not essentially benign.
|
Clin Nucl Med
|
2008
|
0.75
|
|
97
|
Miliary brain metastases in 2 cases with advanced non-small cell lung cancer harboring EGFR mutation during gefitinib treatment.
|
Respir Investig
|
2012
|
0.75
|
|
98
|
[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Lung cancer].
|
Nihon Igaku Hoshasen Gakkai Zasshi
|
2002
|
0.75
|
|
99
|
Optimization of Gd-DTPA-enhanced balanced turbo field echo sequence in abdominal imaging: a basic study.
|
Magn Reson Med Sci
|
2004
|
0.75
|
|
100
|
Sternal Uptake of 99mTc-MAA in Thoracic Outlet Syndrome.
|
Clin Nucl Med
|
2015
|
0.75
|
|
101
|
[Case Report; A case of acute sarcoidosis with fever and polyarthralgia].
|
Nihon Naika Gakkai Zasshi
|
2016
|
0.75
|
|
102
|
[Application of PET/CT fused images in the diagnosis of colorectal cancer].
|
Nihon Rinsho
|
2011
|
0.75
|
|
103
|
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
|
Kaku Igaku
|
2009
|
0.75
|
|
104
|
[Evaluation of pancreatic cancer extent using balanced turbo field echo (bTFE)].
|
Nihon Igaku Hoshasen Gakkai Zasshi
|
2004
|
0.75
|
|
105
|
Discovery of cyclic amine-substituted benzoic acids as PPARα agonists.
|
Bioorg Med Chem Lett
|
2011
|
0.75
|
|
106
|
Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.
|
Jpn J Radiol
|
2011
|
0.75
|
|
107
|
[Imaging diagnosis of biliary tract cancer on PET].
|
Nihon Rinsho
|
2015
|
0.75
|
|
108
|
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study.
|
Ann Nucl Med
|
2009
|
0.75
|